SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is actively trending amid widespread community discussions surrounding a highly controversial incident involving ICE agents in Minneapolis, generating polarized views across social platforms. The stock's strong association with Donald Trump means his public statements on the event are amplifying engagement and driving significant conversation around the symbol.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is generating significant buzz following a robust earnings report, showcasing 250% year-over-year revenue growth and adjusted breakeven earnings. The community is highly optimistic about substantial future expansion, driven by confirmed existing hyperscaler leases and advanced discussions for three new 900MW data center sites, positioning the company as a key AI infrastructure provider. This strong execution, including the strategic cloud business spin-off, is igniting expectations for considerable long-term value creation.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing a dramatic surge in price and trading volume, driven by renewed speculation surrounding its ultra-low share float and high cost to borrow, which the community believes could ignite a significant short squeeze. Traders are actively comparing its current trajectory to its past parabolic rallies to hundreds of dollars, highlighting the extreme volatility and potential for further explosive gains, despite mixed views on its underlying digital identity technology for supply chain traceability.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc is trending amidst significant community speculation surrounding its upcoming mission on a SpaceX rocket, positioning it as a potential "mini SpaceX" within the surging space and defense sector. Traders are actively discussing a massive short squeeze, fueled by an exceptionally low float and soaring borrowing rates, despite recent dilution concerns from a private placement.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is trending amidst intense community discussion, fueled by speculation around a potential short squeeze driven by its ultra-low public float and rapidly increasing borrow fees. Many investors are debating the possibility of another significant upward move, drawing parallels to past volatile Hong Kong-based microcap rallies. Despite ongoing concerns regarding its fundamental valuation and lack of revenue, a strong sentiment persists among traders about a 'float lock' and trapped short positions.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending as discussions on a potential substantial increase in the U.S. military budget for 2027 and a new PAC-3 missile production agreement drive conversation. Community sentiment is mixed, with some expressing frustration over perceived market manipulation and volatility, while others remain bullish on the defense sector's long-term prospects amid heightened global geopolitical risks.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing significant volatility following a political figure's comments on restricting large institutional investors from buying single-family homes, leading to an immediate market downturn. However, the community is deeply divided, with many arguing that this news is fundamentally bullish for Opendoor's model, as it primarily facilitates home transactions for individual buyers rather than acting as a long-term institutional landlord. This perspective suggests the initial sell-off is a market misinterpretation, potentially creating a strong buying opportunity as clarity emerges.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering Corp ($IMRX) is trending amidst mixed community reactions to its 12-month overall survival data for atebimetinib in first-line pancreatic cancer, an area with significant unmet medical need. While many commend the impressive survival rates and improved quality of life compared to historical benchmarks, others express disappointment that the results didn't meet heightened expectations, leading to recent stock volatility. Debates are active around the long-term potential, funding through 2029, and whether institutional buying will drive a rebound against perceived short-seller pressure.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is drawing significant attention after its CES 2026 announcements showcased new Core Ultra Series 3 processors on the cutting-edge 18A process, signaling a major push into AI PCs and broader AI infrastructure. The community is actively debating the validation of Intel's foundry capabilities and its strategic positioning, reinforcing the bullish turnaround thesis and potential for future customer wins.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

PMGC Holdings Inc. (ELAB) is trending due to a recent reverse stock split creating an ultra-low float, combined with news of a strategic investment in a nuclear energy company and a subsidiary achieving aerospace certification. The community is buzzing with speculation about a potential short squeeze, frequently comparing it to other volatile 'low floater' plays, while also navigating concerns about broker buying restrictions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SurgePays (NASDAQ:SURG) Director Buys $61,475.20 in Stock

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) Director David Allen May purchased 38,422 shares of SurgePays stock in a transaction that occurred on Wednesday, December 10th. The stock was acquired...

SurgePays (NASDAQ:SURG) Posts Earnings Results, Misses Estimates By $0.21 EPS

SurgePays (NASDAQ:SURG - Get Free Report) announced its quarterly earnings results on Wednesday. The medical equipment provider reported ($0.38) earnings per share (EPS) for the quarter, missing...

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026...

SurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue Estimates

SurgePays, Inc. (SURG) delivered earnings and revenue surprises of -16.13% and -32.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Porch Group, Inc. (PRCH) Reports Break-Even Earnings for Q2

Porch Group (PRCH) delivered earnings and revenue surprises of +100.00% and +10.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

SurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue Estimates

Shares of nano-cap SurgePays, Inc. (SURG) jumped on Wednesday after the telecom and fintech company issued an upbeat outlook after announcing subpar annual results.The Barlett, Tennessee-based company reported a loss of $2.39 per share and revenue of $60.88 million for the year ended Dec. 31. This compares to the year-ago earnings per share (EPS) of $1.45 and revenue of $137.14 million.&nbsp;SurgePays blamed the predicament on the end of the federally funded Affordable Connectivity Program (ACP).The ACP is a U.S. government-sponsored program administered by the Federal Communications Commission (FCC) that provides affordable internet access to low-income households. The program stopped accepting applications in the first half of 2024, with April 2024 being the last fully-funded month.Even so, the company&nbsp;was upbeat about&nbsp;its outlook. “However, strategic investments made during this transition — including AT&amp;T integration, POS growth, and the development of our MVNE platform — have built the foundation for 2025's goal to return to growth and profitability,” it said.&nbsp;Brian Cox, Chairman and CEO, said, "We built the infrastructure. Now we are scaling. With AT&amp;T integration complete and LinkUp Mobile launching nationally, SurgePays is positioned for the most aggressive revenue growth phase in our history."LinkUp Mobile is the company’s retail prepaid wireless brand.Looking ahead, the company expects&nbsp;over $200 million in revenue over the next 12 months and positive cash flow from operations before the end of 2025, following the successful integration and official launch with AT&amp;T.&nbsp;The revenue guidance for the year is markedly above the Finchat-compiled consensus of $95.11 million.&nbsp;On Stocktwits, retail sentiment toward SurgePays stock stayed ‘extremely bullish’ (100/100) and the message volume spurted to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:637/137;" src="https://news.stocktwits-cdn.com/surg_sentiment_png_b7d7d166fb.webp" alt="surg-sentiment.png" width="637" height="137"><figcaption>SURG sentiment and message volume March 26, as of 12:54 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>A bullish watcher positioned for a multi-day run and predicted a move to $3 on Thursday.<stembedurl>https://stocktwits.com/Harunkaraca/message/609306748</stembedurl>Another user attributed his bullish sentiment to the moving average convergence divergence (MACD) indicator crossing over.<stembedurl>https://stocktwits.com/BananaExpress15/message/609287406</stembedurl><a href="https://stocktwits.com/symbol/SURG">SurgePays stock</a> soared by over 54% to $2.13 on Wednesday afternoon. The stock is down about 22.5% this year. If the gains are sustained, the stock is on track to finish with the biggest one-day gain in four years.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/playtika-receives-double-upgrade-from-bofa/chJbRWxRb3l">Playtika Stock On Track To Record Biggest Single-Day Gain Ever After BofA’s Double Upgrade: Retail’s Exuberant</a>

Rising stock market chart on a trading board background.

SurgePays Stock Surges As Strong Guidance Overshadows FY24 Underperformance: Retail Anticipates Multi-Day Run  

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.

Equity

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.


This Week’s Hottest Themes: Biotech (RFK Jr. Meddling), Space (Trump's Space Force),&nbsp; AI (The Theme of the Year)&nbsp;WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in sectors actively drawing capital. This targeted approach, combined with real-time news surveillance, helps us uncover stocks poised for powerful multi-day or multi-month moves—often long before Wall Street analysts catch on.Here's a list of today's most important names:1. Cassava Sciences (NASDAQ: SAVA)Background: Cassava Sciences is a clinical-stage biotechnology company focused on Alzheimer’s disease. Its investigational drug, Simufilam, has been central to its research efforts.The News: Cassava's stock took a dramatic plunge after disappointing Phase 3 trial results for Simufilam, followed by a social media storm triggered by Martin Shkreli’s scathing critique of the drug’s efficacy. Shkreli, calling Simufilam’s mechanism “implausible,” encouraged short-sellers, predicting a sharp decline in the stock. The failure of the trial and Shkreli’s influence sent shares tumbling by more than 85%, from nearly $30 per share to under $5.What It Means: This setback emphasizes the significant risks in Alzheimer's drug development. With most Alzheimer’s trials failing, investors now question the credibility of Cassava’s lead drug. While the company still has resources to pivot, the stock’s credibility has been deeply shaken, and the road ahead is uncertain.Stock Reaction: Yesterday the stock opened at $30 but closed near $5, reflecting a swift and steep sell-off. The market’s reaction shows how quickly investor sentiment can turn negative on biotech stocks, particularly in high-risk, high-reward sectors like Alzheimer’s treatment.&nbsp;2. Poseida Therapeutics (NASDAQ: PSTX)Background: Poseida is a biopharmaceutical company specializing in gene therapies, particularly CAR-T treatments for cancer.The News: Poseida announced a significant partnership with Roche, securing $110 million upfront and up to $1 billion in potential milestones. This deal is aimed at accelerating Poseida's CAR-T therapies and other cell and gene therapy technologies.What It Means: This collaboration is a major validation for Poseida’s technology, especially in the competitive CAR-T space, which has attracted attention due to its potential to treat cancers. The cash infusion from Roche is expected to fuel further research and development.Stock Reaction: Poseida opened at $9.26, up over 200%, rising slightly to close at $9.38. The market responded favorably to the news, viewing the Roche deal as a solid indication of Poseida’s future potential in the cancer treatment landscape.&nbsp;3. KULR Technology Group (NYSE: KULR)Background: KULR specializes in thermal management technologies for energy storage and aerospace.The News: KULR Technology Group has received a U.S. Navy contract to develop its Internal Short Circuit (ISC) technology to operate at higher temperatures. This upgrade is important for both military and commercial applications, especially in aviation where it aligns with safety standards. The ISC devices, originally developed with NASA and NREL, simulate controlled thermal runaway in lithium-ion cells for more accurate and safer testing of battery behavior in extreme conditions.What It Means: The Navy contract could serve as a major stepping stone for KULR, providing the company with exposure to one of the most demanding industries for thermal solutions. This deal not only enhances KULR’s credibility but may also open doors for similar partnerships in the aerospace and defense sectors.Stock Reaction: The stock opened at $0.80 and climbed another 20% reaching $0.96 by mid-morning on volume that is 1,000%+ higher than average.&nbsp;4. POET Technologies (NASDAQ: POET)Background: POET is a leader in photonics technology, designing advanced semiconductor solutions aimed at AI, telecommunications, and data storage.The News: POET Technologies (NASDAQ: POET) is ramping up production of its optical engines to meet the increasing demand from AI applications. A recent report highlighted that while many companies in the UK are adopting AI, few have integrated it into their manufacturing processes, which could hinder innovation and productivity. The report suggests that government support and regulations could help accelerate AI adoption in industries.What It Means: As AI applications continue to expand, POET’s new platform could be a game-changer. The optical interposer aims to address the bottlenecks in data processing by enabling faster, more efficient communication between chips, which is crucial for AI and big data.Stock Reaction: POET opened at $4.38 and rose to $5.35 (up 22%) by mid-day on volume 3x higher than average.&nbsp;5. SurgePays (NASDAQ: SURG)Background: SurgePays provides financial services and prepaid wireless solutions for underserved markets.The News:&nbsp;SurgePays (SURG) has integrated its ClearLine marketing platform with PAX smart payment terminals, allowing merchants to deliver real-time promotions and offers during transactions. This integration leverages existing hardware to enhance customer engagement and streamline marketing efforts, helping retailers boost loyalty and sales. SurgePays aims to scale its retail presence by utilizing PAX's wide reach in the payment terminal industry.What It Means: SurgePays continues to capitalize on the significant need for affordable financial services and wireless solutions in underserved communities. This strong performance suggests the company’s business model is scaling effectively, positioning it well for future growth.Stock Reaction: SurgePays opened at $2.00 and surged to $2.20, up 10%, trading average volume.&nbsp;6. TOYO Ventures Holdings (NASDAQ: TOYO)Background: TOYO Co., Ltd. is a solar solutions company focused on becoming a full-service provider in the global market. It integrates all stages of the solar power supply chain, including wafer and silicon production, solar cell manufacturing, and photovoltaic module production. TOYO is positioned to produce high-quality solar cells at a competitive scale and cost.The News: TOYO Co., Ltd (Nasdaq: TOYO) has secured a $150 million contract to supply high-efficiency solar cells to a major solar module manufacturer. The agreement will support solar module production in India and the U.S., leveraging TOYO’s advanced manufacturing capabilities in Vietnam and Ethiopia. This contract highlights the company's commitment to sustainable energy and the global shift towards renewable resources.What It Means: The $150 million contract is a major win for TOYO Co., Ltd, solidifying its role as a key player in the solar energy sector. It highlights the company’s advanced manufacturing capabilities and global reach, particularly in India and the U.S. For the market, the deal signals continued growth in the solar industry, boosting confidence in renewable energy technologies and potentially attracting more investment. TOYO’s expanded presence in key markets could strengthen its competitive position as demand for efficient solar cells rises..Stock Reaction: Shares opened at $5.56, up 39% to retrace to $4.50 by mid-morning and closing at $5.41 on eye-poping 1,500x average volume.&nbsp;&nbsp;7. Anavex Life Sciences (NASDAQ: AVXL)Background:&nbsp;Anavex Life Sciences develops treatments for neurodegenerative disorders like Alzheimer's and Parkinson's. Its lead drug, ANAVEX®2-73, has shown positive results in Phase 2 trials, while the company is also developing ANAVEX®3-71 for Alzheimer's.The News:Anavex Life Sciences has submitted a Marketing Authorization Application (MAA) for its drug, blarcamesine (ANAVEX®2-73), to the European Medicines Agency (EMA) for the treatment of Alzheimer’s disease. Blarcamesine, an orally administered small molecule, showed significant clinical improvement in patients over 48 weeks, with better efficacy than approved therapies and a slower rate of neurodegeneration in early Alzheimer's patients. Its safety profile eliminates the need for routine MRI monitoring, making it a promising treatment option.What It Means:&nbsp;The MAA submission for blarcamesine to the EMA is a positive development for Anavex Life Sciences, potentially boosting its stock if approved. If successful, blarcamesine could open new revenue streams and strengthen investor confidence. For the broader market, this signals progress in Alzheimer’s treatment, potentially drawing more investment into biotech, especially in neurodegenerative diseases.Stock Reaction: Anavex opened at $10.30 up 10% from Monday's close, but cratered almost 20% from that high by mid-afternoon closing nearly flat from the previous day's close on slightly higher than average volume.&nbsp;&nbsp;Be The First to Know:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/newsletter-sign-up/">Our email list eats first! Get exclusive alerts on explosive stock picks like AST&nbsp;SpaceMobile (NASDAQ: ASTS) which shot up&nbsp;+533% after our profile. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here.</a>&nbsp;&nbsp;<hr>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/WealthyVC">Follow us on Twitter</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.instagram.com/wealthyventurecapital/">Follow us on Instagram</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/TheWealthyVentureCapitalist/?locale=zh_CN">Follow us on Facebook</a><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion in the WVC Facebook Investor Group</a>Have a Stock Tip or New&nbsp; Story Suggestion? Email us at Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

SurgePays, Inc. operates as a technology-driven company, which focuses on building a supply chain software platform as an alternative to traditional wholesale supply chain distribution models. It offers goods and services direct to convenience stores, bodegas, minimarts, tiendas and other corner stores, providing goods and services primarily to the underbanked community. The company was founded on August 18, 2006 and is headquartered in Bartlett, TN.

Surgepays Inc

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

SURG
Surgepays Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SURG News

SURGSurgepays Inc